Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and characterization of a heterocyclic electrophilic fragment library for the discovery of cysteine-targeted covalent inhibitors
Aaron Keeley, Péter Ábrányi‐Balogh, György M. Keserü
MedChemComm (2018) Vol. 10, Iss. 2, pp. 263-267
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
A. Douangamath, D. Fearon, Paul Gehrtz, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 486
Advances in covalent drug discovery
Lydia Boike, Nathaniel J. Henning, Daniel K. Nomura
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 881-898
Open Access | Times Cited: 481
Rapid Covalent-Probe Discovery by Electrophile-Fragment Screening
Efrat Resnick, A.R. Bradley, Jinrui Gan, et al.
Journal of the American Chemical Society (2019) Vol. 141, Iss. 22, pp. 8951-8968
Open Access | Times Cited: 280
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo A. M. Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 49
Covalent fragment libraries in drug discovery
Aaron Keeley, László Petri, Péter Ábrányi‐Balogh, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 6, pp. 983-996
Open Access | Times Cited: 89
N-Trifluoromethyl Amines and Azoles: An Underexplored Functional Group in the Medicinal Chemist’s Toolbox
Stefan Schießer, Hanna Chepliaka, Johanna Kollback, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 13076-13089
Closed Access | Times Cited: 71
Small-Molecule Thioesters as SARS-CoV-2 Main Protease Inhibitors: Enzyme Inhibition, Structure–Activity Relationships, Antiviral Activity, and X-ray Structure Determination
Thanigaimalai Pillaiyar, Philipp Flury, Nadine Krüger, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9376-9395
Closed Access | Times Cited: 57
Nitriles: an attractive approach to the development of covalent inhibitors
Vinícius Bonatto, Rafael F. Lameiro, Fernanda dos Reis Rocho, et al.
RSC Medicinal Chemistry (2022) Vol. 14, Iss. 2, pp. 201-217
Open Access | Times Cited: 42
Cyanotriazoles are selective topoisomerase II poisons that rapidly cure trypanosome infections
Srinivasa P. S. Rao, Matthew K. Gould, Jonas Noeske, et al.
Science (2023) Vol. 380, Iss. 6652, pp. 1349-1356
Open Access | Times Cited: 24
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6549-6569
Closed Access | Times Cited: 9
Fragment-to-Lead Medicinal Chemistry Publications in 2019
Wolfgang Jahnke, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15494-15507
Open Access | Times Cited: 58
Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities
Robert J. Mayer, Armin R. Ofial
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 49, pp. 17704-17708
Open Access | Times Cited: 57
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors
Kirsten McAulay, Emily Hoyt, Morgan Thomas, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 23, pp. 10358-10372
Open Access | Times Cited: 54
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
A. Douangamath, D. Fearon, Paul Gehrtz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 50
DFT, ADMET, molecular docking and molecular dynamics studies of pyridoxal
Nadezhda A. Garkusha, Oksana P. Anikeeva, İmren Bayıl, et al.
Journal of the Indian Chemical Society (2023) Vol. 100, Iss. 3, pp. 100926-100926
Open Access | Times Cited: 22
Principles and Applications of CF2X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug Discovery
Sebastian Vaas, Markus O. Zimmermann, Dieter Schollmeyer, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 15, pp. 10202-10225
Open Access | Times Cited: 21
Covalent hits and where to find them
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 7
Structural and in silico studies of 2-pyridyl-decorated 2-amino-1,3,5-triazine with a potency against SARS-CoV-2 proteins
Damir A. Safin
Comptes Rendus Chimie (2024) Vol. 27, Iss. G1, pp. 153-166
Open Access | Times Cited: 7
Multicomponent reaction–derived covalent inhibitor space
Fandi Sutanto, Shabnam Shaabani, Constantinos G. Neochoritis, et al.
Science Advances (2021) Vol. 7, Iss. 6
Open Access | Times Cited: 39
Screening for Inhibitors of Main Protease in SARS-CoV-2: In Silico and In Vitro Approach Avoiding Peptidyl Secondary Amides
Kazuki Yamamoto, Nobuaki Yasuo, Masakazu Sekijima
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 2, pp. 350-358
Open Access | Times Cited: 28
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis
Endri Karaj, Shaimaa H. Sindi, Nishanth Kuganesan, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 17, pp. 11788-11817
Open Access | Times Cited: 26
Development of the First Covalent Monopolar Spindle Kinase 1 (MPS1/TTK) Inhibitor
Ricardo A. M. Serafim, André da Silva Santiago, Martin P. Schwalm, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3173-3192
Closed Access | Times Cited: 24
Covalent chemical probes for protein kinases
Ricardo A. M. Serafim, Lisa Haarer, Júlia G. B. Pedreira, et al.
Current Research in Chemical Biology (2023) Vol. 3, pp. 100040-100040
Open Access | Times Cited: 16
Computational studies of closely related 2-cyanopyrimidine, pyrimidine-2-carboximidamide and 2,4,6-tris(2-pyrimidyl)-1,3,5-triazine with a potency against SARS-CoV-2
Tuğba Taşkın‐Tok, Damir A. Safin
Monatshefte für Chemie - Chemical Monthly (2023) Vol. 155, Iss. 1, pp. 57-71
Open Access | Times Cited: 14
The role of quantum chemistry in covalent inhibitor design
Levente M. Mihalovits, György G. Ferenczy, György M. Keserü
International Journal of Quantum Chemistry (2021) Vol. 122, Iss. 8
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top